Organization
Molecular Diagnostics Firm Mainz Biomed Prices $22.5M Follow-on Share Offering
In the first half of this year, the firm intends to launch a clinical study and begin the submission process to obtain FDA clearance for its colorectal cancer diagnostic test.
Dante Labs to Refund COVID-19 Test Customers Following UK Regulatory Investigation
The move comes as the UK's Competition and Markets Authority cracks down on PCR test providers for price gouging and other improper business practices.
AnPac Bio Warned by Nasdaq Over Listing Requirement
The company has until July 18 to meet Nasdaq compliance by getting its market value of publicly held shares to at least $15 million.
Maxim Biomedical OTC COVID-19 Antigen Test Nabs FDA Emergency Use Authorization
The test delivers results in 15 minutes and is for identifying the SARS-CoV-2 nucleocapsid protein antigen in symptomatic and asymptomatic individuals.
Stanford researchers said the cost of their approach is in line with Illumina sequencing but did not share data on error rate and other benchmarks at this time.